Statin Intensity Regimens in Thai Type 2 Diabetic Patients
Who Achieved LDL-C Targets
Brian Lee MD*, Korrakod Dumrongkitchaiporn MD**,
Sutin Sriussadaporn MD**, Nuntakorn Thongtang MD**
Affiliation :
* Division of Endocrinology and Metabolism, Department of Medicine,
HRH Princess Maha Chakri Sirindhorn Medical Center, Faculty of Medicine,
Srinakharinwirot University, Nakhon Nayok, Thailand
** Division of Endocrinology and Metabolism, Department of Medicine,
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Background : Type 2 diabetes mellitus (T2D) increases the risk of developing atherosclerotic cardiovascular disease
(ASCVD). Statins reduce ASCVD events and are recommended in patients with T2D. Low-, moderate, and high-intensity
regimens are predicted to achieve LDL-C reduction by about <30%, 30% to <50%, and ≥50%, respectively.
Objective : To investigate the proportions of different statin intensity regimens used in patients with T2D that achieved LDL-C
targets.
Material and Method: This retrospective cross-sectional study was conducted in 269 T2D adults with LDL-C <100 mg/dL
that were stratified into three groups by statin intensity according to 2013 ACC/AHA guideline. Factors significantly
associated with higher-intensity statin use were determined by multivariate analysis.
Results : Subjects were mostly elderly with long-standing T2D and hypertension (HT). Prevalence of ASCVD was 12.3%.
Only 8.9% received high-intensity statins, while 40.9% and 50.2% received low- and moderate-intensity statins, respectively.
Overall, attainment of LDL-C <70 mg/dL was 52.8%. Average LDL-C reduction was 54.6% (49.6%, 54.4%, and 59.7% in
the low-, moderate-, and high-intensity groups, respectively). Rates of ASCVD, HT, and smoking were higher in the high-
intensity group. Factors significantly correlated with higher-intensity statin therapy included diabetic nephropathy (DN),
HT, high-density lipoprotein cholesterol (HDL-C), and non-HDL-C levels (OR: 2.633, 2.381, 1.027, and 1.037, respectively).
Conclusion : Low- and moderate-intensity statin users accounted for about 90% of Thai T2D patients who achieved LDL-C
<100 mg/dL. LDL-C reduction in these two groups was greater than anticipated. HT and DN were associated with the use
of higher-intensity statins to achieve LDL-C targets.
Keywords : statin intensity, LDL-C target, LDL-C reduction, type 2 diabetes mellitus
All Articles
Download